---
title: "Weekly Recap | Alpha Tau Medical -3.99%, pulling back after the early spike"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298801201.md"
description: "Alpha Tau Medical (DRTS) closed the week down 3.99% at $14.43, underperforming the S&P 500’s 0.80% decline by about 3.19 percentage points. The week opened firm on Tuesday (Sep 8), peaking at $15.08, before sliding to a weekly low of $13.80 on Thursday (Sep 10). Friday (Sep 11) was choppy and finished near the prior close at $14.43. Weekly amplitude was 8.52%, with average daily volume of 460.6k shares, around 19% below the 60-day median."
datetime: "2026-09-12T08:07:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298801201.md)
  - [en](https://longbridge.com/en/news/298801201.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298801201.md)
generator: "portal-rs"
---

# Weekly Recap | Alpha Tau Medical -3.99%, pulling back after the early spike

## The Week

Alpha Tau Medical (DRTS) closed the week down 3.99% at $14.43, underperforming the S&P 500’s 0.80% decline by about 3.19 percentage points. The week opened firm on Tuesday (Sep 8), peaking at $15.08, before sliding to a weekly low of $13.80 on Thursday (Sep 10). Friday (Sep 11) was choppy and finished near the prior close at $14.43. Weekly amplitude was 8.52%, with average daily volume of 460.6k shares, around 19% below the 60-day median. With no major announcements or results out this week, the move mostly tracked broader market sentiment.

## Analyst Ratings

Coverage is thin. Five brokers rate the stock: three buy, one overweight, one hold, and none underweight or sell. The consensus rating is buy. The consensus target price sits at $17.80, about 23.35% above the latest price of $14.43. Targets are widely spread, from $8.00 at the low end to $30.00 at the high end, signalling a meaningful gap in views. Within medical devices, its industry rating rank is 62 out of 142.

## The Week Ahead

A run of US macro data lands next week: the Empire State manufacturing index on Tuesday (Sep 15), followed by retail sales and import prices on Wednesday (Sep 16). DRTS has no scheduled results of its own, so near-term price action will likely hinge on the broader tape and sector risk appetite.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [DRTS.US](https://longbridge.com/en/quote/DRTS.US.md)

## Related News & Research

- [Alpha Tau Medical Ltd. (TASE:DRTS) Posts Strong Early Cancer Trial Signals; Key Readouts Ahead](https://longbridge.com/en/news/299216743.md)
- [Alpha Tau completes enrollment in 48-patient IMPACT pancreatic cancer Alpha DaRT pilot study](https://longbridge.com/en/news/297513505.md)
- [Micron Stock's (MU) AI Lead Is Expanding beyond HBM. I'm Bullish](https://longbridge.com/en/news/299626350.md)
- [Jensen Huang Says AI CEOs May Have 'Ulterior', Maybe 'Political' Reasons For AI Doomsday Warnings: 'Go and Read Between The Lines'](https://longbridge.com/en/news/299637656.md)
- [Michael Saylor Says, 'A Little More Orange': Will Strategy Report BTC Purchases After Hitting Pause for 3 Weeks?](https://longbridge.com/en/news/299601303.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**